New Biden order wants CMMI to test payment models that tackle high drug prices Flying glass fears force Exela to recall 49 lots of metabolic acidosis injection Alcon, J&J Vision settle for $75M in contact lens price-fixing case FDA scraps AdComm for Reata's rare disease candidate, leaving analysts squinting at the tea leaves Takeda's Qdenga nears approval in EU, and beyond, thanks to special regulatory pathway UnitedHealth bracing for Medicaid redeterminations to resume Invivyd faces C-suite departures, commercial layoffs as turmoil continues at rebranded Adagio A green revolution: FDA hands down emergency OK to plant-based surgical face mask Despite pandemic slowdown, biosimilars keep gaining market share in the US, Amgen report says Enliven Therapeutics, troubled Imara set to merge with Roche-backed $165M fundraise CommonSpirit Health: Ransomware attack responsible for ongoing IT outages Omics startup Pleno prospers with $40M funding round FDA’s liver safety request set to delay decision on Travere’s kidney drug | 